Form 4 for DXCM Dexcom

Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-08 · accession 0001093557-25-000065 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-03-11	2025-03-08	DXCM	Leach Jacob Steven	EVP, COO	A - Grant	$0.00	+58.7K	304.8K	+24%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-03-08	A	A	22,798	$0.00	327,573	D	—	—	(F2) Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting from the date of grant as follows: 1/2 shall vest on March 8, 2026, 1/8 shall vest on May 22, 2026, 1/8 shall vest on August 22, 2026, 1/8 shall vest on November 8, 2026, and the remaining balance shall vest on March 8, 2027. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. (F3) Included in this number are 84,537 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 8,465 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 225 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 28, 2025.
2	Common	Common Stock	2025-03-08	A	A	35,906	$0.00	304,775	D	—	—	(F1) Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.